Septerna, Inc. Common Stock
Symbol: SEPN (NASDAQ)
0.00
▼ (-100.00%) -16.000
Company Description:
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $16
- Yesterday High: $16.2
- Yesterday Low: $15.41
- Yesterday Volume: 205.82K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Septerna, Inc. Common Stock
- Website: https://septerna.com
- Listed Date: 2024-10-25
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001984086
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $699.99M
- Round Lot: 100
- Outstanding Shares: 44.59M
- Asset Type: CS
RECENT FILINGS FOR SEPN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 8-K | View |
| 2025-08-21 | 8-K | View |
| 2025-08-19 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-04 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |